GenKyoTex S.A. 's First in Class NOX Inhibitor GKT137831 to be Presented at Kidney Week 2012
10/15/2012 10:18:39 AM
More...
|
GenKyoTex S.A. s Lead NOX Inhibitor GKT137831 Demonstrates Activity in Models of Liver Fibrosis
8/8/2012 10:21:51 AM
More...
|
GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug
7/9/2012 7:18:28 AM
More...
|
GenKyoTex S.A. Announces Successful Phase Ia Data with First in Class NOX Inhibitor GKT137831
6/22/2012 10:14:44 AM
More...
|
GenKyoTex S.A. Starts Phase I Trial with First in Class NOX Inhibitor GKT137831
11/2/2011 10:28:38 AM
More...
|